Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Keurig Dr Pepper gains after report of activist Starboard stake (SeekingAlpha) +++ KEURIG DR PEPPER Aktie +3,68%

News zum Sektor Gesundheit aus Asien

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 102 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1577 Aktien zum Sektor Gesundheit bekannt.
 
13.10.25 - 18:36
Mosman Oil and Gas, Helix Exploration, Helium One, Thor Explorations, KEFI, ImmuPharma (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
13.10.25 - 13:00
Zacks.com featured highlights include StoneCo, Universal Health Services, Integer Holdings and Great Lakes Dredge & Dock (Zacks)
 
Zacks highlights STNE, UHS, ITGR, and GLDD as value stocks with strong cash flow and growth potential amid earnings and government shutdown concerns....
13.10.25 - 06:03
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress (GlobeNewswire EN)
 
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal cell carcinoma patients after progression on first-line therapies...
13.10.25 - 04:54
Hong Kong stocks post longest decline in 9 months on renewed US-China tensions (SCMP)
 
Hong Kong stocks fell for a sixth day on Monday, the longest losing streak in nine months, as a flare-up in US-China trade tensions kept investors on edge. The Hang Seng Index fell 2.2 per cent to 25,705.68 as of 10.05am local time, matching a six-day run in early January. The Hang Seng Tech Index dropped 2.5 per cent. On the mainland, the CSI 300 Index slid 1.7 per cent and the Shanghai Composite Index retreated 1.4 per cent. Biotech major WuXi AppTec, which has a huge exposure to the US,......
13.10.25 - 02:12
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development (PR Newswire)
 
- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, which supports once-monthly subcutaneous (SQ) dosing in humans. - In head-to-head NHP studies, drug exposures of ASC35 intravenous (I.V.) and......
12.10.25 - 15:06
top global stories this week: HSBC, Novo Nordisk, Nikon among notable names (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.10.25 - 17:30
Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? (Zacks)
 
Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....
10.10.25 - 15:03
Zura Bio slips after CEO announces medical leave (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.10.25 - 14:06
Dividend Roundup: Lockheed Martin, Pfizer, Genpact, Delta Air Lines, and more (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.10.25 - 10:01
Data from GNT-018-IDES trial supports feasibility of imlifidase as pretreatment in gene therapy treatment for patients with Crigler–Najjar syndrome who are immune to AAV (Cision)
 
Results presented today at ESGCT 2025 PARIS, France, LUND, Sweden (October 10, 2025) - Genethon, a worldwide pioneer and leader in research and development of gene therapy for rare genetic diseases, and Hansa Biopharma, a Sweden-based leader in IgG cleaving enzyme technology announced today that a patient with a rare liver disease and immunity to the AAV vector has been successfully treated with Genethon's AAV-based GNT0003 gene therapy for Crigler-Najjar syndrome, following prior administration of imlifidase, an enzyme capable of temporarily inhibiting the immune response. This encouraging...
10.10.25 - 02:33
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year (PR Newswire)
 
SHANGHAI, Oct. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced it has received the esteemed AAA ESG rating from Morgan Stanley Capital International (MSCI) for the third consecutive year.......
09.10.25 - 13:06
Biopharma Leaders Advance the Future of Life Sciences at Veeva Commercial Summit Europe (PR Newswire)
 
Industry gathers to explore Veeva AI innovations and exchange ideas with companies including Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna, and MSD BARCELONA, Spain, Oct. 9, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Astellas, Bayer AG, Boehringer......
09.10.25 - 10:00
CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest (AAStocks)
 
CKLIFE SCIENCES (00775.HK) announced that its Polynoma will merge with TransCode Therapeutics (RNAZ.US), and they have entered into a share purchase and preferred stock financing agreement.Initially, CKLIFE SCIENCES will hold about 9.1% of TransCode's shares and receive non-voting preferred stock. Once all preferred shares a......
09.10.25 - 06:18
Zukauf von ABB: Softbank zündet nächste KI-Stufe – Physical AI (Wallstreet-Online)
 
Der japanische Beteiligungskonzern unterstreicht einmal mehr, das er im Bereich KI ein großer Player werden möchte. Nach Kooperationen mit Chat GPT und Tempus AI geht Softbank das nächste große Thema an: Physical AI!Jetzt den vollständigen Artikel lesen...
09.10.25 - 06:15
Midday Takeaway: HSI Closes Midday at 26,840, Up 11 pts; HSTI Closes Midday at 6,555, Up 41 pts; HANG SENG BANK Up over 26%; HANG SENG BANK, ZIJIN MINING, WUXI APPTEC, CHINAHONGQIAO, SH ELECTRIC Hit New Highs (AAStocks)
 
At midday close, HSI rose 11 pts or 0.0% to 26,840. HSTI rose 41 pts or 0.6% to 6,555. HSCEI gained 49 pts or 0.5% to 9,573.Active Heavyweights:MEITUAN (03690.HK) closed at $104.5, up 0.8%BABA (09988.HK) closed at $176.4, down 0.7%XIAOMI (01810.HK) closed at $53.75, down 0.2%TENCENT (00700.HK) closed at $674.5, down 0.1%HSI & HS......
09.10.25 - 05:45
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 (PR Newswire)
 
RIO DE JANEIRO, Oct. 8, 2025 /PRNewswire/ -- Anbio Biotechnology participated in the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), an international gathering that brought together veterinarians, researchers, and industry representatives from more than 100 countries.......
09.10.25 - 04:30
WUXI XDC Slumps ~5% on Reported Shareholder STA Pharmaceutical's Stake Cut at 6.5% Discount (AAStocks)
 
STA Pharmaceutical Hong Kong Investment, a shareholder of WUXI XDC (02268.HK), placed 30.3 million shares of WUXI XDC at HKD77.42 per share through Morgan Stanley, Bloomberg reported, citing filing. This represents a discount of nearly 6.5% compared to the closing price of HKD82.8 yesterday (8th).WUXI XDC’s share price cam......
09.10.25 - 04:30
IMMUNEONCO-B Tumbles 12%+ on ~13% Discounted Shr Placement (AAStocks)
 
After announcing a 12.97% discounted share placement, IMMUNEONCO-B (01541.HK) opened 5.7% lower this morning (9th) and once bottomed at HKD14.41. It last traded at HKD14.59, down 12.42%, with a volume of 3.992 million shares, involving HKD60.7679 million.IMMUNEONCO-B intends to place 24.2 million new H-shares (5.6% of the enlarg......
09.10.25 - 03:48
CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs (SCMP)
 
CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech unit controlled by the Li Ka-shing family. The agreement paved the way for TransCode to acquire the parent company of Polynoma from DEFJ, an indirect wholly owned unit of CK Life, the latter said in a filing with the Hong Kong stock exchange after trading hours on Wednesday. In exchange, TransCode......
09.10.25 - 01:30
Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting (PR Newswire)
 
Presentations include long-term GATHER2 open-label extension data, real-world treatment patterns on safety, and biomarker insights on geographic atrophy disease progression TOKYO, Oct. 8, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas")......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Sie taten Ihre Schuldigkeit. Ich weiß den Mann von seinem Amt zu unterscheiden. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!